HADH (Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial; also known as SCHAD, HAD1, M/SCHAD) is a soluble mitochondrial matrix enzyme that catalyzes the third step of the fatty-acid beta-oxidation spiral: the NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA to 3-ketoacyl-CoA (EC 1.1.1.35). It acts as a homodimer and preferentially oxidizes short- and medium-chain 3-hydroxyacyl-CoA substrates (roughly C4-C10), functionally distinct from the long-chain, membrane-associated mitochondrial trifunctional protein alpha subunit (HADHA). Catalysis uses His158 as a general base assisted by Glu170. Beyond its catalytic role, HADH has a well-documented regulatory (moonlighting) function in pancreatic beta-cells: it binds and inhibits the activation of glutamate dehydrogenase 1 (GLUD1), thereby restraining amino-acid-stimulated insulin secretion. Loss of HADH function causes hyperinsulinaemic hypoglycaemia and a fatty-acid-oxidation disorder, establishing the first known link between beta-oxidation and dysregulated insulin secretion. HADH is expressed in liver, kidney, pancreatic islets, heart, skeletal muscle, and adipose tissue, and in rodents contributes to body-weight regulation and adaptive thermogenesis.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred core molecular function. This is the defining catalytic activity of HADH/SCHAD, directly demonstrated for the human enzyme by purified-protein biochemistry and crystallography and by patient-mutant expression studies. The IBA call is at the correct level of specificity and is strongly corroborated by experimental annotations on the same term.
Reason: Bona fide enzymatic function supported across the 3-hydroxyacyl-CoA dehydrogenase family and by direct human experimental data (PMID:10231530, PMID:11489939, PMID:16725361).
Supporting Evidence:
PMID:10231530
catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH
|
|
GO:0005739
mitochondrion
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: HADH is a mitochondrial matrix enzyme, so a mitochondrial location is correct. However, 'mitochondrion' is the generic parent of the more precise and experimentally supported 'mitochondrial matrix' (GO:0005759). Correct but non-core; the matrix term should carry the core localization.
Reason: Correct compartment but less specific than the supported mitochondrial matrix annotation.
|
|
GO:0006635
fatty acid beta-oxidation
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core biological process. HADH catalyzes the third step of the mitochondrial beta-oxidation cycle; this is its principal pathway role, supported by enzymology, the UniProt-curated pathway assignment, and patient deficiency phenotypes.
Reason: Directly supported by experimental data and UniProt pathway curation (lipid metabolism; fatty acid beta-oxidation).
Supporting Evidence:
PMID:11489939
This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic (multi-method) inference of the core catalytic activity. Redundant with the experimental and IBA annotations on the same term and correct.
Reason: Same correct molecular function as the experimentally supported annotation.
|
|
GO:0005759
mitochondrial matrix
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Correct and specific subcellular localization derived from the UniProt subcellular-location vocabulary. HADH is a soluble matrix homodimer; this is the appropriate core location term and is independently supported by TAS (Reactome) and high-confidence mitochondrial proteomics.
Reason: Matches the curated UniProt 'Mitochondrion matrix' location and is the most precise localization for HADH.
|
|
GO:0006631
fatty acid metabolic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: Correct but generic. 'Fatty acid metabolic process' is a high-level parent of the specific and experimentally supported 'fatty acid beta-oxidation' (GO:0006635). Keep as non-core in favor of the more informative beta-oxidation term.
Reason: Subsumed by the more specific beta-oxidation annotation.
|
|
GO:0016491
oxidoreductase activity
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: Correct but maximally generic molecular-function class. HADH is an NAD+-dependent oxidoreductase, but this term is a distant parent of the specific GO:0003857 activity.
Reason: Generic parent of the specific dehydrogenase activity; uninformative as a standalone core function.
|
|
GO:0016509
long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IEA
GO_REF:0000116 |
MARK AS OVER ANNOTATED |
Summary: This Rhea-mapped annotation asserts long-chain (C16) 3-hydroxyacyl-CoA dehydrogenase activity. HADH is the SHORT/medium-chain enzyme (preferring C4-C10); the long-chain matrix activity is the dedicated function of HADHA (MTP alpha subunit). UniProt lists a long-chain Rhea reaction for HADH only 'By similarity' to pig liver SCHAD (P00348), not as a preferred human activity. Annotating HADH with the long-chain-specific term misrepresents substrate preference and overlaps the distinct HADHA function.
Reason: HADH preferentially oxidizes short/medium-chain (C4-C10) 3-hydroxyacyl-CoAs; long-chain activity is minor/by-similarity and is the defining role of the paralog HADHA. The substrate-general GO:0003857 already captures the correct activity.
|
|
GO:0016616
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: Correct but generic intermediate parent of GO:0003857. Accurately describes the chemistry (oxidation of a CH-OH group with NAD+ as acceptor) but is less informative than the specific activity term.
Reason: Generic parent of the specific 3-hydroxyacyl-CoA dehydrogenase activity.
|
|
GO:0070403
NAD+ binding
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: NAD+ is the cofactor for the dehydrogenase reaction and binding is documented crystallographically. Correct molecular detail of the catalytic mechanism; complementary to (and subordinate to) the core dehydrogenase activity rather than a standalone core function.
Reason: Cofactor-binding activity supporting the core catalytic function; also captured by the IDA annotation from PMID:10840044.
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Correct mitochondrial localization by orthology transfer, but generic relative to the specific 'mitochondrial matrix' term.
Reason: Less specific than the supported mitochondrial matrix annotation.
|
|
GO:0006635
fatty acid beta-oxidation
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic inference of the core beta-oxidation process, redundant with and consistent with the experimental (IDA) and IBA annotations on this term.
Reason: Correct core biological process supported by experimental evidence.
|
|
GO:0009410
response to xenobiotic stimulus
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Electronically transferred from a rodent ortholog (rat Q9WVK7). A generic physiological 'response' term with no mechanistic link to HADH's molecular function; weakly informative and not part of the gene's core biology.
Reason: Orthology-transferred generic response term; not contradicted but low information and not a core function.
|
|
GO:0009725
response to hormone
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Generic 'response to hormone' transferred electronically from a rodent ortholog. Broad and mechanistically uninformative for HADH.
Reason: Orthology-transferred generic term; non-core.
|
|
GO:0014823
response to activity
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Generic physiological response term transferred from a rodent ortholog; not informative about HADH molecular function.
Reason: Orthology-transferred generic term; non-core.
|
|
GO:0032868
response to insulin
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Generic 'response to insulin' transferred from a rodent ortholog. While HADH biology is linked to insulin (through its regulatory effect ON secretion), 'response to insulin' is a distinct, broad term and is mechanistically uninformative here.
Reason: Orthology-transferred generic response term; the relevant insulin biology is captured by the regulation-of-insulin-secretion annotations.
|
|
GO:0046676
negative regulation of insulin secretion
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Captures HADH's regulatory (moonlighting) role in pancreatic beta-cells: by binding and inhibiting GLUD1, HADH restrains amino-acid-stimulated insulin secretion, so its loss leads to inappropriate insulin oversecretion (hyperinsulinism). This is the more mechanistically precise insulin-secretion term and is well supported by human disease and mouse knockout data. Genuine secondary function.
Reason: Well-supported regulatory function (GDH inhibition / restraint of insulin secretion), but secondary to the core beta-oxidation enzymatic role.
Supporting Evidence:
PMID:21990309
insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice
|
|
GO:0050796
regulation of insulin secretion
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Parent term of 'negative regulation of insulin secretion'. Correct and supported, but less precise than the negative-regulation child that matches the GDH-inhibition mechanism.
Reason: Correct regulatory role but subsumed by the more specific negative-regulation term.
|
|
GO:0120162
positive regulation of cold-induced thermogenesis
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Based on the mouse Hadh knockout phenotype (impaired cold tolerance / adaptive thermogenesis). This is a downstream physiological consequence of impaired fatty-acid oxidation rather than a distinct molecular function of HADH; appropriate to retain as a non-core, organism-level process.
Reason: Mouse-derived physiological phenotype downstream of FAO; non-core.
Supporting Evidence:
PMID:21990309
SCHAD plays an important role in adaptive thermogenesis
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
KEEP AS NON CORE |
Summary: Direct (immunofluorescence/HPA) evidence for mitochondrial localization. Correct; generic relative to the matrix sub-compartment but a valid experimental localization.
Reason: Experimentally supported mitochondrial localization, less specific than mitochondrial matrix.
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
EXP
PMID:10231530 Biochemical characterization and crystal structure determina... |
ACCEPT |
Summary: Direct experimental demonstration of the core catalytic activity via purified recombinant human heart SCHAD, kinetics, and crystal structures of the enzyme with NAD+ and substrate. This is the strongest evidence for HADH's defining molecular function.
Reason: Gold-standard experimental evidence for the core dehydrogenase activity.
Supporting Evidence:
PMID:10231530
catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
EXP
PMID:16725361 Reye-like syndrome resulting from novel missense mutations i... |
ACCEPT |
Summary: Experimental support from kinetic analysis of patient-derived missense mutants (D45G with altered NADH Km; Y214H with no detectable activity), directly assaying the human SCHAD 3-hydroxyacyl-CoA dehydrogenase activity.
Reason: Independent experimental confirmation of the core dehydrogenase activity through mutant enzymology.
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
KEEP AS NON CORE |
Summary: High-throughput high-confidence mitochondrial proteomics confirming HADH as a mitochondrial protein. Correct; generic relative to the matrix term but a valid orthogonal localization evidence source.
Reason: Supports mitochondrial localization; less specific than mitochondrial matrix.
|
|
GO:0050796
regulation of insulin secretion
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: Sequence-similarity transfer (from mouse Q61425) of HADH's regulatory role in insulin secretion. Reflects the GDH-inhibition moonlighting mechanism. Correct and supported, but less precise than the negative-regulation child term and secondary to the core enzymatic function.
Reason: Genuine but secondary regulatory function; the negative-regulation term is more precise.
Supporting Evidence:
PMID:21990309
Blood glucose concentrations in the fasted and postprandial state were significantly lower in hadh(-/-) mice, whereas insulin levels were elevated
|
|
GO:0070403
NAD+ binding
|
IDA
PMID:10840044 Sequestration of the active site by interdomain shifting. Cr... |
KEEP AS NON CORE |
Summary: Direct crystallographic/spectroscopic evidence for NAD+/NADH binding within distinct enzyme conformations. A molecular detail underpinning the catalytic mechanism; complementary to the core dehydrogenase activity.
Reason: Cofactor-binding activity supporting, but subordinate to, the core catalytic function.
Supporting Evidence:
PMID:10840044
significant shifting of the NAD(+)-binding domain relative to the C-terminal domain occurs in the ternary and substrate-bound complexes
|
|
GO:0042802
identical protein binding
|
IDA
PMID:10231530 Biochemical characterization and crystal structure determina... |
KEEP AS NON CORE |
Summary: Reflects the fact that HADH is an obligate homodimer, established by crystallography and biochemistry. This is a quaternary-structure descriptor ('identical protein binding') rather than the bare uninformative 'protein binding', and it is experimentally grounded. It is not, however, a core catalytic/regulatory function in its own right.
Reason: Experimentally supported self-association (homodimerization); structural property rather than a core function.
Supporting Evidence:
PMID:10231530
The homodimeric enzyme has been overexpressed in Escherichia coli, purified to homogeneity
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
IDA
PMID:11489939 Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydroge... |
ACCEPT |
Summary: Direct assay of the core activity in patient material and recombinant enzyme: SCHAD activity was markedly reduced in patient fibroblast mitochondria and the P258L variant had no catalytic activity, confirming HADH as the enzyme catalyzing this reaction.
Reason: Experimental loss-of-function evidence directly tying HADH to the 3-hydroxyacyl-CoA dehydrogenase activity.
Supporting Evidence:
PMID:11489939
Expression studies showed that the P258L enzyme had no catalytic activity
|
|
GO:0006635
fatty acid beta-oxidation
|
IDA
PMID:11489939 Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydroge... |
ACCEPT |
Summary: Direct evidence linking HADH to beta-oxidation: deficiency produces a fatty-acid-oxidation disorder with characteristic 3-hydroxy-acylcarnitine accumulation, the first FAO defect associated with hyperinsulinism.
Reason: Experimentally supported core biological process (beta-oxidation).
Supporting Evidence:
PMID:11489939
This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism
|
|
GO:0120162
positive regulation of cold-induced thermogenesis
|
ISS
PMID:21990309 Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrog... |
KEEP AS NON CORE |
Summary: Sequence-similarity annotation citing the mouse Hadh knockout thermogenesis phenotype. Downstream physiological consequence of impaired fatty-acid oxidation rather than a distinct molecular function; retain as non-core.
Reason: Mouse-derived organismal phenotype downstream of FAO; non-core.
Supporting Evidence:
PMID:21990309
SCHAD plays an important role in adaptive thermogenesis
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-77254 |
ACCEPT |
Summary: Reactome traceable assertion placing HADH in the mitochondrial matrix as part of a beta-oxidation reaction (3-hydroxydodecanoyl-CoA oxidation). Correct, specific localization consistent with UniProt.
Reason: Correct, specific mitochondrial matrix localization from curated pathway data.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-77312 |
ACCEPT |
Summary: Reactome matrix localization within the short-chain (3-hydroxybutanoyl-CoA) beta-oxidation reaction. Correct and consistent with the curated location.
Reason: Correct mitochondrial matrix localization from curated pathway data.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-77323 |
ACCEPT |
Summary: Reactome matrix localization within the hexanoyl-CoA beta-oxidation reaction. Correct, consistent with curated location.
Reason: Correct mitochondrial matrix localization from curated pathway data.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-77331 |
ACCEPT |
Summary: Reactome matrix localization within the octanoyl-CoA beta-oxidation reaction. Correct, consistent with curated location.
Reason: Correct mitochondrial matrix localization from curated pathway data.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-77342 |
ACCEPT |
Summary: Reactome matrix localization within the decanoyl-CoA beta-oxidation reaction. Correct, consistent with curated location.
Reason: Correct mitochondrial matrix localization from curated pathway data.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9838035 |
ACCEPT |
Summary: This Reactome reaction is 'CLPXP binds mitochondrial matrix proteins'; HADH is annotated here as a matrix substrate of the quality-control protease, which correctly localizes it to the matrix. The location assertion is valid; it does not imply any protease/degradation function for HADH itself.
Reason: Valid matrix localization arising from HADH being a CLPXP substrate (localization-only, not a HADH function).
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9838081 |
ACCEPT |
Summary: Reactome 'LONP1 degrades mitochondrial matrix proteins'; HADH appears as a matrix substrate, correctly localizing it to the matrix. Location-only evidence, not a degradation function of HADH.
Reason: Valid matrix localization from HADH being a LONP1 substrate (localization-only).
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9838093 |
ACCEPT |
Summary: Reactome 'LONP1 binds mitochondrial matrix proteins'; HADH appears as a matrix substrate. Correct localization; location-only, not a HADH function.
Reason: Valid matrix localization from HADH being a LONP1 substrate (localization-only).
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-9838289 |
ACCEPT |
Summary: Reactome 'CLPXP degrades mitochondrial matrix proteins'; HADH appears as a matrix substrate. Correct localization; location-only, not a HADH function.
Reason: Valid matrix localization from HADH being a CLPXP substrate (localization-only).
|
|
GO:0005737
cytoplasm
|
IDA
GO_REF:0000054 |
MARK AS OVER ANNOTATED |
Summary: A LIFEdb annotation based on localization of an expressed fluorescent fusion protein in living cells. HADH is a mitochondrial matrix enzyme with a cleavable N-terminal mitochondrial targeting peptide; a cytoplasmic call most likely reflects mislocalization of the overexpressed fusion construct (e.g., incomplete import or a tag obscuring the transit peptide) rather than the native location. Contradicted by curated UniProt localization, Reactome, HPA, and high-confidence mitochondrial proteomics.
Reason: Likely overexpression/fusion-protein artifact; HADH is matrix-localized, not cytoplasmic.
|
|
GO:0003857
(3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
|
TAS
PMID:8687463 Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning... |
ACCEPT |
Summary: Traceable assertion from the original human SCHAD cDNA cloning/characterization paper, which identified the protein as short-chain L-3-hydroxyacyl-CoA dehydrogenase. Correct core molecular function.
Reason: Consistent with the experimentally established core dehydrogenase activity.
Supporting Evidence:
PMID:8687463
The cDNA encompassing the complete coding sequence of human liver short-chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) was isolated and characterized
|
|
GO:0005739
mitochondrion
|
TAS
PMID:8687463 Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning... |
KEEP AS NON CORE |
Summary: Traceable assertion of mitochondrial localization from the cloning paper, which identified a 12-residue mitochondrial import signal peptide. Correct; generic relative to the matrix term.
Reason: Correct mitochondrial localization, less specific than mitochondrial matrix.
Supporting Evidence:
PMID:8687463
containing a mitochondrial import signal peptide of 12 amino acids
|
Q: To what extent is HADH's regulation of insulin secretion mediated by direct GLUD1 inhibition versus by perturbation of short-chain acyl-CoA/3-hydroxyacyl-CoA pools from impaired beta-oxidation, and are these mechanisms separable in human beta-cells?
Q: Is the HADH-GLUD1 inhibitory interaction conserved and direct in human tissue (as opposed to the By-similarity/mouse-based evidence currently underpinning it), and what is its stoichiometry and regulation?
Experiment: Reconstitute purified human HADH with human GLUD1 in vitro and measure GLUD1 activity +/- HADH (and +/- HADH catalytic-dead mutants) to determine whether enzyme-inhibitor activity is independent of HADH's own catalysis.
Experiment: Generate beta-cell models expressing a catalytically dead but folding-competent HADH variant versus full knockout to dissociate the dehydrogenase activity from the GLUD1-inhibition / insulin-secretion-restraint function.
Experiment: Perform substrate-profiling (chain-length kinetics) on purified human HADH across C4-C16 3-hydroxyacyl-CoAs to quantitatively confirm short/medium-chain preference and the negligible long-chain activity relative to HADHA.
Gene: HADH (HGNC:4799); aka SCHAD, HAD1, HADHSC, M/SCHAD.
Protein: Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH_HUMAN). 314 aa precursor;
12-aa mitochondrial transit peptide; mature 13-314. EC 1.1.1.35.
HADH catalyzes the third step of the mitochondrial fatty-acid beta-oxidation spiral: the
NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA to 3-ketoacyl-CoA.
Distinct from HADHA (the long-chain, membrane-bound MTP alpha subunit). HADH is a soluble
matrix homodimer.
Mitochondrion matrix. [Q16836 UniProt SUBCELLULAR LOCATION "Mitochondrion matrix
{ECO:0000305|PubMed:8687463}."] Confirmed by high-confidence mitochondrial proteomics
[PMID:34800366 mitochondrial proteome, HTP]. Note a legacy LIFEdb IDA "cytoplasm" annotation
(GO:0005737) likely reflects an overexpressed GFP-fusion artifact, not the native location.
Expressed in liver, kidney, pancreas, heart and skeletal muscle. PMID:8687463 Notably expressed in islets of Langerhans PMID:21990309.
Loss-of-function HADH mutations cause hyperinsulinaemic hypoglycaemia. This was the FIRST
fatty-acid-oxidation defect associated with hyperinsulinism, revealing a link between FAO and
insulin secretion.
Disease (UniProt): HADH deficiency [MIM:231530] (hypoglycemia, hepatoencephalopathy, myopathy/
cardiomyopathy, sudden death) and Hyperinsulinemic hypoglycemia familial 4 (HHF4) [MIM:609975].
(OMIM also uses HHF7 in some sources; UniProt entry uses HHF4.)
Mouse KO data implicate Hadh in adaptive thermogenesis and body-weight regulation.
PMID:21990309 and
PMID:21990309 The GO term positive regulation of cold-induced thermogenesis
(GO:0120162) is ISS from mouse — a downstream physiological consequence of impaired FAO, not a
distinct molecular function; treat as non-core.
UniProt: [Q16836 UniProt FUNCTION "Plays a role in the maintenance of normal spermatogenesis
through the reduction of fatty acid accumulation in the testes (By similarity)."] Keyword-derived
GO:0007283 (IEA from UniProtKB-KW). Downstream/By-similarity; non-core.
id: Q16836
gene_symbol: HADH
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
HADH (Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial; also known as SCHAD, HAD1,
M/SCHAD) is a soluble mitochondrial matrix enzyme that catalyzes the third step of the
fatty-acid beta-oxidation spiral: the NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA
to 3-ketoacyl-CoA (EC 1.1.1.35). It acts as a homodimer and preferentially oxidizes short-
and medium-chain 3-hydroxyacyl-CoA substrates (roughly C4-C10), functionally distinct from
the long-chain, membrane-associated mitochondrial trifunctional protein alpha subunit (HADHA).
Catalysis uses His158 as a general base assisted by Glu170. Beyond its catalytic role, HADH
has a well-documented regulatory (moonlighting) function in pancreatic beta-cells: it binds
and inhibits the activation of glutamate dehydrogenase 1 (GLUD1), thereby restraining
amino-acid-stimulated insulin secretion. Loss of HADH function causes hyperinsulinaemic
hypoglycaemia and a fatty-acid-oxidation disorder, establishing the first known link between
beta-oxidation and dysregulated insulin secretion. HADH is expressed in liver, kidney,
pancreatic islets, heart, skeletal muscle, and adipose tissue, and in rodents contributes to
body-weight regulation and adaptive thermogenesis.
alternative_products:
- name: '1'
id: Q16836-1
- name: '2'
id: Q16836-2
sequence_note: VSP_016551, VSP_016552
- name: '3'
id: Q16836-3
sequence_note: VSP_016552
existing_annotations:
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetically inferred core molecular function. This is the defining catalytic activity
of HADH/SCHAD, directly demonstrated for the human enzyme by purified-protein biochemistry
and crystallography and by patient-mutant expression studies. The IBA call is at the correct
level of specificity and is strongly corroborated by experimental annotations on the same
term.
action: ACCEPT
reason: >-
Bona fide enzymatic function supported across the 3-hydroxyacyl-CoA dehydrogenase family and
by direct human experimental data (PMID:10231530, PMID:11489939, PMID:16725361).
supported_by:
- reference_id: PMID:10231530
supporting_text: "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
HADH is a mitochondrial matrix enzyme, so a mitochondrial location is correct. However,
'mitochondrion' is the generic parent of the more precise and experimentally supported
'mitochondrial matrix' (GO:0005759). Correct but non-core; the matrix term should carry the
core localization.
action: KEEP_AS_NON_CORE
reason: >-
Correct compartment but less specific than the supported mitochondrial matrix annotation.
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Core biological process. HADH catalyzes the third step of the mitochondrial beta-oxidation
cycle; this is its principal pathway role, supported by enzymology, the UniProt-curated
pathway assignment, and patient deficiency phenotypes.
action: ACCEPT
reason: >-
Directly supported by experimental data and UniProt pathway curation (lipid metabolism;
fatty acid beta-oxidation).
supported_by:
- reference_id: PMID:11489939
supporting_text: "This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism"
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic (multi-method) inference of the core catalytic activity. Redundant with the
experimental and IBA annotations on the same term and correct.
action: ACCEPT
reason: >-
Same correct molecular function as the experimentally supported annotation.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Correct and specific subcellular localization derived from the UniProt subcellular-location
vocabulary. HADH is a soluble matrix homodimer; this is the appropriate core location term
and is independently supported by TAS (Reactome) and high-confidence mitochondrial proteomics.
action: ACCEPT
reason: >-
Matches the curated UniProt 'Mitochondrion matrix' location and is the most precise
localization for HADH.
- term:
id: GO:0006631
label: fatty acid metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
Correct but generic. 'Fatty acid metabolic process' is a high-level parent of the specific
and experimentally supported 'fatty acid beta-oxidation' (GO:0006635). Keep as non-core in
favor of the more informative beta-oxidation term.
action: KEEP_AS_NON_CORE
reason: >-
Subsumed by the more specific beta-oxidation annotation.
- term:
id: GO:0016491
label: oxidoreductase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
Correct but maximally generic molecular-function class. HADH is an NAD+-dependent
oxidoreductase, but this term is a distant parent of the specific GO:0003857 activity.
action: KEEP_AS_NON_CORE
reason: >-
Generic parent of the specific dehydrogenase activity; uninformative as a standalone core
function.
- term:
id: GO:0016509
label: long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
This Rhea-mapped annotation asserts long-chain (C16) 3-hydroxyacyl-CoA dehydrogenase
activity. HADH is the SHORT/medium-chain enzyme (preferring C4-C10); the long-chain matrix
activity is the dedicated function of HADHA (MTP alpha subunit). UniProt lists a long-chain
Rhea reaction for HADH only 'By similarity' to pig liver SCHAD (P00348), not as a preferred
human activity. Annotating HADH with the long-chain-specific term misrepresents substrate
preference and overlaps the distinct HADHA function.
action: MARK_AS_OVER_ANNOTATED
reason: >-
HADH preferentially oxidizes short/medium-chain (C4-C10) 3-hydroxyacyl-CoAs; long-chain
activity is minor/by-similarity and is the defining role of the paralog HADHA. The
substrate-general GO:0003857 already captures the correct activity.
- term:
id: GO:0016616
label: oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP
as acceptor
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
Correct but generic intermediate parent of GO:0003857. Accurately describes the chemistry
(oxidation of a CH-OH group with NAD+ as acceptor) but is less informative than the specific
activity term.
action: KEEP_AS_NON_CORE
reason: >-
Generic parent of the specific 3-hydroxyacyl-CoA dehydrogenase activity.
- term:
id: GO:0070403
label: NAD+ binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
NAD+ is the cofactor for the dehydrogenase reaction and binding is documented
crystallographically. Correct molecular detail of the catalytic mechanism; complementary to
(and subordinate to) the core dehydrogenase activity rather than a standalone core function.
action: KEEP_AS_NON_CORE
reason: >-
Cofactor-binding activity supporting the core catalytic function; also captured by the IDA
annotation from PMID:10840044.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: located_in
review:
summary: >-
Correct mitochondrial localization by orthology transfer, but generic relative to the
specific 'mitochondrial matrix' term.
action: KEEP_AS_NON_CORE
reason: >-
Less specific than the supported mitochondrial matrix annotation.
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
Electronic inference of the core beta-oxidation process, redundant with and consistent with
the experimental (IDA) and IBA annotations on this term.
action: ACCEPT
reason: >-
Correct core biological process supported by experimental evidence.
- term:
id: GO:0009410
label: response to xenobiotic stimulus
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Electronically transferred from a rodent ortholog (rat Q9WVK7). A generic physiological
'response' term with no mechanistic link to HADH's molecular function; weakly informative
and not part of the gene's core biology.
action: KEEP_AS_NON_CORE
reason: >-
Orthology-transferred generic response term; not contradicted but low information and not a
core function.
- term:
id: GO:0009725
label: response to hormone
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Generic 'response to hormone' transferred electronically from a rodent ortholog. Broad and
mechanistically uninformative for HADH.
action: KEEP_AS_NON_CORE
reason: >-
Orthology-transferred generic term; non-core.
- term:
id: GO:0014823
label: response to activity
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Generic physiological response term transferred from a rodent ortholog; not informative
about HADH molecular function.
action: KEEP_AS_NON_CORE
reason: >-
Orthology-transferred generic term; non-core.
- term:
id: GO:0032868
label: response to insulin
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Generic 'response to insulin' transferred from a rodent ortholog. While HADH biology is
linked to insulin (through its regulatory effect ON secretion), 'response to insulin' is a
distinct, broad term and is mechanistically uninformative here.
action: KEEP_AS_NON_CORE
reason: >-
Orthology-transferred generic response term; the relevant insulin biology is captured by the
regulation-of-insulin-secretion annotations.
- term:
id: GO:0046676
label: negative regulation of insulin secretion
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Captures HADH's regulatory (moonlighting) role in pancreatic beta-cells: by binding and
inhibiting GLUD1, HADH restrains amino-acid-stimulated insulin secretion, so its loss leads
to inappropriate insulin oversecretion (hyperinsulinism). This is the more mechanistically
precise insulin-secretion term and is well supported by human disease and mouse knockout
data. Genuine secondary function.
action: KEEP_AS_NON_CORE
reason: >-
Well-supported regulatory function (GDH inhibition / restraint of insulin secretion), but
secondary to the core beta-oxidation enzymatic role.
supported_by:
- reference_id: PMID:21990309
supporting_text: "insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice"
- term:
id: GO:0050796
label: regulation of insulin secretion
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Parent term of 'negative regulation of insulin secretion'. Correct and supported, but less
precise than the negative-regulation child that matches the GDH-inhibition mechanism.
action: KEEP_AS_NON_CORE
reason: >-
Correct regulatory role but subsumed by the more specific negative-regulation term.
- term:
id: GO:0120162
label: positive regulation of cold-induced thermogenesis
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: >-
Based on the mouse Hadh knockout phenotype (impaired cold tolerance / adaptive
thermogenesis). This is a downstream physiological consequence of impaired fatty-acid
oxidation rather than a distinct molecular function of HADH; appropriate to retain as a
non-core, organism-level process.
action: KEEP_AS_NON_CORE
reason: >-
Mouse-derived physiological phenotype downstream of FAO; non-core.
supported_by:
- reference_id: PMID:21990309
supporting_text: "SCHAD plays an important role in adaptive thermogenesis"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: >-
Direct (immunofluorescence/HPA) evidence for mitochondrial localization. Correct; generic
relative to the matrix sub-compartment but a valid experimental localization.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally supported mitochondrial localization, less specific than mitochondrial matrix.
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: EXP
original_reference_id: PMID:10231530
qualifier: enables
review:
summary: >-
Direct experimental demonstration of the core catalytic activity via purified recombinant
human heart SCHAD, kinetics, and crystal structures of the enzyme with NAD+ and substrate.
This is the strongest evidence for HADH's defining molecular function.
action: ACCEPT
reason: >-
Gold-standard experimental evidence for the core dehydrogenase activity.
supported_by:
- reference_id: PMID:10231530
supporting_text: "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: EXP
original_reference_id: PMID:16725361
qualifier: enables
review:
summary: >-
Experimental support from kinetic analysis of patient-derived missense mutants (D45G with
altered NADH Km; Y214H with no detectable activity), directly assaying the human SCHAD
3-hydroxyacyl-CoA dehydrogenase activity.
action: ACCEPT
reason: >-
Independent experimental confirmation of the core dehydrogenase activity through mutant
enzymology.
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
qualifier: located_in
review:
summary: >-
High-throughput high-confidence mitochondrial proteomics confirming HADH as a mitochondrial
protein. Correct; generic relative to the matrix term but a valid orthogonal localization
evidence source.
action: KEEP_AS_NON_CORE
reason: >-
Supports mitochondrial localization; less specific than mitochondrial matrix.
- term:
id: GO:0050796
label: regulation of insulin secretion
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: >-
Sequence-similarity transfer (from mouse Q61425) of HADH's regulatory role in insulin
secretion. Reflects the GDH-inhibition moonlighting mechanism. Correct and supported, but
less precise than the negative-regulation child term and secondary to the core enzymatic
function.
action: KEEP_AS_NON_CORE
reason: >-
Genuine but secondary regulatory function; the negative-regulation term is more precise.
supported_by:
- reference_id: PMID:21990309
supporting_text: "Blood glucose concentrations in the fasted and postprandial state were significantly lower in hadh(-/-) mice, whereas insulin levels were elevated"
- term:
id: GO:0070403
label: NAD+ binding
evidence_type: IDA
original_reference_id: PMID:10840044
qualifier: enables
review:
summary: >-
Direct crystallographic/spectroscopic evidence for NAD+/NADH binding within distinct enzyme
conformations. A molecular detail underpinning the catalytic mechanism; complementary to the
core dehydrogenase activity.
action: KEEP_AS_NON_CORE
reason: >-
Cofactor-binding activity supporting, but subordinate to, the core catalytic function.
supported_by:
- reference_id: PMID:10840044
supporting_text: "significant shifting of the NAD(+)-binding domain relative to the C-terminal domain occurs in the ternary and substrate-bound complexes"
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IDA
original_reference_id: PMID:10231530
qualifier: enables
review:
summary: >-
Reflects the fact that HADH is an obligate homodimer, established by crystallography and
biochemistry. This is a quaternary-structure descriptor ('identical protein binding') rather
than the bare uninformative 'protein binding', and it is experimentally grounded. It is not,
however, a core catalytic/regulatory function in its own right.
action: KEEP_AS_NON_CORE
reason: >-
Experimentally supported self-association (homodimerization); structural property rather than
a core function.
supported_by:
- reference_id: PMID:10231530
supporting_text: "The homodimeric enzyme has been overexpressed in Escherichia coli, purified to homogeneity"
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: IDA
original_reference_id: PMID:11489939
qualifier: enables
review:
summary: >-
Direct assay of the core activity in patient material and recombinant enzyme: SCHAD activity
was markedly reduced in patient fibroblast mitochondria and the P258L variant had no
catalytic activity, confirming HADH as the enzyme catalyzing this reaction.
action: ACCEPT
reason: >-
Experimental loss-of-function evidence directly tying HADH to the 3-hydroxyacyl-CoA
dehydrogenase activity.
supported_by:
- reference_id: PMID:11489939
supporting_text: "Expression studies showed that the P258L enzyme had no catalytic activity"
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: IDA
original_reference_id: PMID:11489939
qualifier: involved_in
review:
summary: >-
Direct evidence linking HADH to beta-oxidation: deficiency produces a fatty-acid-oxidation
disorder with characteristic 3-hydroxy-acylcarnitine accumulation, the first FAO defect
associated with hyperinsulinism.
action: ACCEPT
reason: >-
Experimentally supported core biological process (beta-oxidation).
supported_by:
- reference_id: PMID:11489939
supporting_text: "This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism"
- term:
id: GO:0120162
label: positive regulation of cold-induced thermogenesis
evidence_type: ISS
original_reference_id: PMID:21990309
qualifier: involved_in
review:
summary: >-
Sequence-similarity annotation citing the mouse Hadh knockout thermogenesis phenotype.
Downstream physiological consequence of impaired fatty-acid oxidation rather than a distinct
molecular function; retain as non-core.
action: KEEP_AS_NON_CORE
reason: >-
Mouse-derived organismal phenotype downstream of FAO; non-core.
supported_by:
- reference_id: PMID:21990309
supporting_text: "SCHAD plays an important role in adaptive thermogenesis"
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-77254
qualifier: located_in
review:
summary: >-
Reactome traceable assertion placing HADH in the mitochondrial matrix as part of a
beta-oxidation reaction (3-hydroxydodecanoyl-CoA oxidation). Correct, specific localization
consistent with UniProt.
action: ACCEPT
reason: >-
Correct, specific mitochondrial matrix localization from curated pathway data.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-77312
qualifier: located_in
review:
summary: >-
Reactome matrix localization within the short-chain (3-hydroxybutanoyl-CoA) beta-oxidation
reaction. Correct and consistent with the curated location.
action: ACCEPT
reason: >-
Correct mitochondrial matrix localization from curated pathway data.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-77323
qualifier: located_in
review:
summary: >-
Reactome matrix localization within the hexanoyl-CoA beta-oxidation reaction. Correct,
consistent with curated location.
action: ACCEPT
reason: >-
Correct mitochondrial matrix localization from curated pathway data.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-77331
qualifier: located_in
review:
summary: >-
Reactome matrix localization within the octanoyl-CoA beta-oxidation reaction. Correct,
consistent with curated location.
action: ACCEPT
reason: >-
Correct mitochondrial matrix localization from curated pathway data.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-77342
qualifier: located_in
review:
summary: >-
Reactome matrix localization within the decanoyl-CoA beta-oxidation reaction. Correct,
consistent with curated location.
action: ACCEPT
reason: >-
Correct mitochondrial matrix localization from curated pathway data.
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9838035
qualifier: located_in
review:
summary: >-
This Reactome reaction is 'CLPXP binds mitochondrial matrix proteins'; HADH is annotated
here as a matrix substrate of the quality-control protease, which correctly localizes it to
the matrix. The location assertion is valid; it does not imply any protease/degradation
function for HADH itself.
action: ACCEPT
reason: >-
Valid matrix localization arising from HADH being a CLPXP substrate (localization-only, not a
HADH function).
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9838081
qualifier: located_in
review:
summary: >-
Reactome 'LONP1 degrades mitochondrial matrix proteins'; HADH appears as a matrix substrate,
correctly localizing it to the matrix. Location-only evidence, not a degradation function of
HADH.
action: ACCEPT
reason: >-
Valid matrix localization from HADH being a LONP1 substrate (localization-only).
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9838093
qualifier: located_in
review:
summary: >-
Reactome 'LONP1 binds mitochondrial matrix proteins'; HADH appears as a matrix substrate.
Correct localization; location-only, not a HADH function.
action: ACCEPT
reason: >-
Valid matrix localization from HADH being a LONP1 substrate (localization-only).
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9838289
qualifier: located_in
review:
summary: >-
Reactome 'CLPXP degrades mitochondrial matrix proteins'; HADH appears as a matrix substrate.
Correct localization; location-only, not a HADH function.
action: ACCEPT
reason: >-
Valid matrix localization from HADH being a CLPXP substrate (localization-only).
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: GO_REF:0000054
qualifier: located_in
review:
summary: >-
A LIFEdb annotation based on localization of an expressed fluorescent fusion protein in
living cells. HADH is a mitochondrial matrix enzyme with a cleavable N-terminal mitochondrial
targeting peptide; a cytoplasmic call most likely reflects mislocalization of the
overexpressed fusion construct (e.g., incomplete import or a tag obscuring the transit
peptide) rather than the native location. Contradicted by curated UniProt localization,
Reactome, HPA, and high-confidence mitochondrial proteomics.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Likely overexpression/fusion-protein artifact; HADH is matrix-localized, not cytoplasmic.
- term:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
evidence_type: TAS
original_reference_id: PMID:8687463
qualifier: enables
review:
summary: >-
Traceable assertion from the original human SCHAD cDNA cloning/characterization paper, which
identified the protein as short-chain L-3-hydroxyacyl-CoA dehydrogenase. Correct core
molecular function.
action: ACCEPT
reason: >-
Consistent with the experimentally established core dehydrogenase activity.
supported_by:
- reference_id: PMID:8687463
supporting_text: "The cDNA encompassing the complete coding sequence of human liver short-chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) was isolated and characterized"
- term:
id: GO:0005739
label: mitochondrion
evidence_type: TAS
original_reference_id: PMID:8687463
qualifier: located_in
review:
summary: >-
Traceable assertion of mitochondrial localization from the cloning paper, which identified a
12-residue mitochondrial import signal peptide. Correct; generic relative to the matrix term.
action: KEEP_AS_NON_CORE
reason: >-
Correct mitochondrial localization, less specific than mitochondrial matrix.
supported_by:
- reference_id: PMID:8687463
supporting_text: "containing a mitochondrial import signal peptide of 12 amino acids"
core_functions:
- description: >-
Core enzymatic function: HADH catalyzes the third step of the mitochondrial fatty-acid
beta-oxidation spiral, the NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA to
3-ketoacyl-CoA, acting as a soluble homodimer in the mitochondrial matrix and preferring
short/medium-chain (C4-C10) substrates.
molecular_function:
id: GO:0003857
label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
directly_involved_in:
- id: GO:0006635
label: fatty acid beta-oxidation
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:10231530
supporting_text: "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
- reference_id: PMID:11489939
supporting_text: "Expression studies showed that the P258L enzyme had no catalytic activity"
- description: >-
Secondary (moonlighting) regulatory function: in pancreatic beta-cells HADH binds and
inhibits the activation of glutamate dehydrogenase 1 (GLUD1), thereby restraining
amino-acid-stimulated insulin secretion. Loss of HADH de-represses GLUD1 and causes
inappropriate insulin oversecretion (hyperinsulinaemic hypoglycaemia), a phenotype
reproduced in Hadh knockout mice and partly independent of beta-oxidation flux. The
underlying molecular activity is enzyme (GLUD1) inhibitor activity; the physiological
output is negative regulation of insulin secretion.
molecular_function:
id: GO:0004857
label: enzyme inhibitor activity
directly_involved_in:
- id: GO:0046676
label: negative regulation of insulin secretion
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:20670938
supporting_text: "showed protein-protein interactions between SCHAD and GDH"
- reference_id: PMID:20670938
supporting_text: "reflecting the loss of an inhibitory protein-protein interaction of SCHAD upon GDH"
- reference_id: PMID:21990309
supporting_text: "insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice"
proposed_new_terms: []
suggested_questions:
- question: >-
To what extent is HADH's regulation of insulin secretion mediated by direct GLUD1 inhibition
versus by perturbation of short-chain acyl-CoA/3-hydroxyacyl-CoA pools from impaired
beta-oxidation, and are these mechanisms separable in human beta-cells?
- question: >-
Is the HADH-GLUD1 inhibitory interaction conserved and direct in human tissue (as opposed to
the By-similarity/mouse-based evidence currently underpinning it), and what is its
stoichiometry and regulation?
suggested_experiments:
- description: >-
Reconstitute purified human HADH with human GLUD1 in vitro and measure GLUD1 activity +/-
HADH (and +/- HADH catalytic-dead mutants) to determine whether enzyme-inhibitor activity is
independent of HADH's own catalysis.
- description: >-
Generate beta-cell models expressing a catalytically dead but folding-competent HADH variant
versus full knockout to dissociate the dehydrogenase activity from the GLUD1-inhibition /
insulin-secretion-restraint function.
- description: >-
Perform substrate-profiling (chain-length kinetics) on purified human HADH across C4-C16
3-hydroxyacyl-CoAs to quantitatively confirm short/medium-chain preference and the negligible
long-chain activity relative to HADHA.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000054
title: Gene Ontology annotation based on curation of intracellular localizations
of expressed fusion proteins in living cells
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000116
title: Automatic Gene Ontology annotation based on Rhea mapping
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:10231530
title: Biochemical characterization and crystal structure determination of human
heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic
mechanism.
findings:
- statement: >-
Human heart SCHAD catalyzes NAD+-dependent oxidation of L-3-hydroxyacyl-CoA to a 3-keto
product as part of beta-oxidation; the enzyme is a homodimer and was characterized
biochemically and crystallographically with NAD+/substrate.
supporting_text: "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
- statement: >-
Catalytic mechanism: His158 acts as a general base abstracting the 3-OH proton, assisted by
Glu170.
supporting_text: "His 158 serves as a general base, abstracting a proton from the 3-OH group of the substrate"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified primary biochemistry/structure paper establishing the human SCHAD core
catalytic activity, homodimer, and mechanism. Abstract-only in cache.
- id: PMID:10840044
title: Sequestration of the active site by interdomain shifting. Crystallographic
and spectroscopic evidence for distinct conformations of L-3-hydroxyacyl-CoA dehydrogenase.
findings:
- statement: >-
Crystal structures of apo-, cofactor-, and substrate-bound forms reveal NAD+-binding domain
shifting relative to the C-terminal domain; supports NAD+ binding and catalytic mechanism.
supporting_text: "significant shifting of the NAD(+)-binding domain relative to the C-terminal domain occurs in the ternary and substrate-bound complexes"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified structural follow-up supporting NAD+ binding and the catalytic conformational
cycle. Abstract-only in cache.
- id: PMID:11489939
title: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency
reveals the importance of beta-oxidation in insulin secretion.
findings:
- statement: >-
First report linking a fatty-acid-oxidation defect (SCHAD/HADH deficiency, P258L) to
hyperinsulinism, establishing HADH's role in insulin-secretion regulation.
supporting_text: "This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism"
- statement: >-
The disease-causing P258L variant abolishes catalytic activity, directly tying HADH to the
3-hydroxyacyl-CoA dehydrogenase reaction.
supporting_text: "Expression studies showed that the P258L enzyme had no catalytic activity"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified case report establishing the HADH-hyperinsulinism link and confirming loss of
catalytic activity in a pathogenic variant. Abstract-only in cache.
- id: PMID:16725361
title: Reye-like syndrome resulting from novel missense mutations in mitochondrial
medium- and short-chain l-3-hydroxy-acyl-CoA dehydrogenase.
findings:
- statement: >-
Kinetic analysis of patient-derived M/SCHAD mutants (D45G altered NADH Km; Y214H no activity)
confirms the human enzyme's 3-hydroxyacyl-CoA dehydrogenase activity and broadens the
phenotype; supports a role in insulin regulation.
supporting_text: "This association suggests that there is a role for M/SCHAD in regulating the pancreatic secretion of insulin"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified case report with mutant enzymology supporting the core activity and the
insulin-regulation role. Abstract-only in cache.
- id: PMID:20670938
title: Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase
deficiency involves activation of glutamate dehydrogenase.
findings:
- statement: >-
Definitive mechanistic paper: pull-down experiments demonstrate a direct protein-protein
interaction between SCHAD (HADH) and glutamate dehydrogenase (GDH), and show that SCHAD
deficiency activates GDH by removing this inhibitory interaction, dysregulating
amino-acid-stimulated insulin secretion. Establishes the GLUD1-inhibitor moonlighting
function on firmer footing than the earlier speculative reports.
supporting_text: "reflecting the loss of an inhibitory protein-protein interaction of SCHAD upon GDH"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified, full text available; provides the definitive protein-protein interaction and
loss-of-inhibition evidence for the HADH/GLUD1 regulatory function.
- id: PMID:21990309
title: Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrogenase in the
regulation of body weight and thermogenesis.
findings:
- statement: >-
Hadh-knockout mice show low glucose and elevated insulin, and isolated islets hypersecrete
insulin in response to glucose and palmitate, supporting HADH's negative regulation of
insulin secretion.
supporting_text: "insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice"
- statement: >-
Hadh knockout impairs adaptive thermogenesis and body-weight regulation under high-fat/cold
conditions.
supporting_text: "SCHAD plays an important role in adaptive thermogenesis"
- statement: >-
SCHAD/HADH is highly expressed in pancreatic islets of Langerhans, consistent with a direct
role in beta-cell function.
supporting_text: "in the islets of Langerhans within the pancreas"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified mouse knockout study (full text available) supporting insulin-secretion
regulation, thermogenesis, and islet expression.
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings:
- statement: >-
HADH is identified in a high-confidence quantitative human mitochondrial proteome,
corroborating its mitochondrial localization.
supporting_text: "Quantitative high-confidence human mitochondrial proteome and its dynamics"
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
High-throughput mitochondrial proteomics providing orthogonal support for mitochondrial
localization.
- id: PMID:8687463
title: 'Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization
of the coding sequence.'
findings:
- statement: >-
Original cloning of human SCHAD cDNA; encodes a 314-aa protein with a 12-residue
mitochondrial import peptide; expressed in liver, kidney, pancreas, heart and skeletal
muscle.
supporting_text: "Northern blot analysis reveals SCHAD mRNA to be expressed in liver, kidney, pancreas, heart and skeletal muscle"
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified original characterization establishing identity, mitochondrial targeting, and
tissue expression. Abstract-only in cache.
- id: Reactome:R-HSA-77254
title: (S)-3-Hydroxydodecanoyl-CoA+NAD => 3-Oxododecanoyl-CoA+NADH+H
findings: []
- id: Reactome:R-HSA-77312
title: (S)-Hydroxybutanoyl-CoA+NAD => Acetoacetyl-CoA+NADH+H
findings: []
- id: Reactome:R-HSA-77323
title: (S)-Hydroxyhexanoyl-CoA+NAD => 3-Oxohexanoyl-CoA+NADH+H
findings: []
- id: Reactome:R-HSA-77331
title: (S)-Hydroxyoctanoyl-CoA+NAD => 3-Oxooctanoyl-CoA+NADH+H
findings: []
- id: Reactome:R-HSA-77342
title: (S)-Hydroxydecanoyl-CoA+NAD => 3-Oxodecanoyl-CoA+NADH+H
findings: []
- id: Reactome:R-HSA-9838035
title: CLPXP binds mitochondrial matrix proteins
findings: []
- id: Reactome:R-HSA-9838081
title: LONP1 degrades mitochondrial matrix proteins
findings: []
- id: Reactome:R-HSA-9838093
title: LONP1 binds mitochondrial matrix proteins
findings: []
- id: Reactome:R-HSA-9838289
title: CLPXP degrades mitochondrial matrix proteins
findings: []